Prions on the run: How extracellular vesicles serve as delivery vehicles for self-templating protein aggregates

Abstract

Extracellular vesicles (EVs) are actively secreted, membrane-bound communication vehicles that exchange biomolecules between cells. EVs also serve as dissemination vehicles for pathogens, including prions, proteinaceous infectious agents that cause transmissible spongiform encephalopathies (TSEs) in mammals. Increasing evidence accumulates that diverse protein aggregates associated with common neurodegenerative diseases are packaged into EVs as well. Vesicle-mediated intercellular transmission of protein aggregates can induce aggregation of homotypic proteins in acceptor cells and might thereby contribute to disease progression. Our knowledge of how protein aggregates are sorted into EVs and how these vesicles adhere to and fuse with target cells is limited. Here we review how TSE prions exploit EVs for intercellular transmission and compare this to the transmission behavior of self-templating cytosolic protein aggregates derived from the yeast prion domain Sup 35 NM. Artificial NM prions are non-toxic to mammalian cell cultures and do not cause loss-of-function phenotypes. Importantly, NM particles are also secreted in association with exosomes that horizontally transmit the prion phenotype to naive bystander cells, a process that can be monitored with high accuracy by automated high throughput confocal microscopy. The high abundance of mammalian proteins with amino acid stretches compositionally similar to yeast prion domains makes the NM cell model an attractive model to study self-templating and dissemination properties of proteins with prion-like domains in the mammalian context.

Discovering Putative Prion-Like Proteins in Plasmodium falciparum: A Computational and Experimental Analysis

“…Other biological process terms could also be arranged into enriched clusters: “protein localization,” “regulation of vesicle-mediated transport,” and “metabolic process.” Importantly, the vesicle-mediated transport system and the trafficking of parasite proteins to diverse locations in the host cell are essential to promote new parasite phenotypes, playing a crucial role in host-pathogen interactions, as well as in disease pathogenesis and susceptibility ( Miller et al, 2002 ; Hiller et al, 2004 ; Marti et al, 2005 ). Indeed, extracellular vesicles have been shown to act as delivery agents for prion-like proteins ( Liu et al, 2017 ).…”

MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

“…Knockdown of integrin Itga8, a predicted target of miR-877-5p and -410-3p, is sufficient to convert prion-resistant neuroblastoma cells to a susceptible phenotype [ 63 ]. Of note, many transmembrane ECM proteins are also structural components of extracellular vesicles [ 64 ], secreted membrane-bound vehicles that exchange various biomolecules between cells, and PrPC expression has been shown to stimulate exosome secretion in some setups [ 65 ]. Glutaminergic synapse pathway has been linked to sCJD risk in a recent large genome-wide association study [ 45 ].…”

Modularized Extracellular Vesicles: The Dawn of Prospective Personalized and Precision Medicine

“…1, 2, 3 According to their subcellular origin, EVs can be mainly classified into two categories: microvesicles (MVs, also known as ectosomes or microparticles, 100–1000 nm in diameter), which are released after formation by budding from the cytomembrane, and exosomes (Exos, 30–100 nm in diameter), which are produced inside multivesicular bodies (MVBs) and released after fusion of the MVBs with the cytomembrane 4, 5, 6. In addition, apoptotic bodies (800–5000 nm in diameter), which are shed into the extracellular environment from apoptotic cells, have several characteristics in common with MVs but are rarely involved in intracellular communication compared to MVs 4.…”